{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T05:01:34Z","timestamp":1780203694806,"version":"3.54.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA035714"],"award-info":[{"award-number":["DA035714"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA047924"],"award-info":[{"award-number":["DA047924"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA057866"],"award-info":[{"award-number":["DA057866"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178131","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:52:00Z","timestamp":1757659920000},"page":"178131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mutational effects of the asparagine198 and glutamate223 residues on the human norepinephrine transporter on basal and HIV-1 Tat protein-induced inhibition of dopamine transport"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4126-6644","authenticated-orcid":false,"given":"Katherine Darby","family":"Porter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-8560","authenticated-orcid":false,"given":"Charles","family":"Adeniran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Catya","family":"Jimenez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Lee","family":"Pless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abagail Brenda","family":"Cirincione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harper","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-7269","authenticated-orcid":false,"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178131_bib1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acschemneuro.0c00792","article-title":"Binding mode of human norepinephrine transporter interacting with HIV-1 tat","volume":"12","author":"Adeniran","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178131_bib66","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1038\/srep15650","article-title":"Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter","volume":"5","author":"Andersen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178131_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/026988110001400304","article-title":"HIV dementia: the role of the basal ganglia and dopaminergic systems","volume":"14","author":"Berger","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-199401000-00010","article-title":"Cerebrospinal fluid dopamine in HIV-1 infection","volume":"8","author":"Berger","year":"1994","journal-title":"AIDS"},{"key":"10.1016\/j.ejphar.2025.178131_bib4","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1073\/pnas.91.26.12584","article-title":"Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium","volume":"91","author":"Buck","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178131_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11481-006-9017-3","article-title":"Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS","volume":"1","author":"Buckner","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/imr.12068","article-title":"Monocyte\/Macrophages and their role in HIV neuropathogenesis","volume":"254","author":"Burdo","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2025.178131_bib7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.neuroimage.2008.05.011","article-title":"Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse","volume":"42","author":"Chang","year":"2008","journal-title":"Neuroimage"},{"issue":"24","key":"10.1016\/j.ejphar.2025.178131_bib67","doi-asserted-by":"crossref","first-page":"10257","DOI":"10.1523\/JNEUROSCI.18-24-10257.1998","article-title":"Cocaine acts as an apparent competitive inhibitor at the outward-facing conformation of the human norepinephrine transporter: kinetic analysis of inward and outward transport","volume":"18","author":"Chen","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178131_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s11481-013-9505-1","article-title":"Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale","volume":"8","author":"Cross","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2004.09.006","article-title":"Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates","volume":"28","author":"Dalley","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2025.178131_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.122.001291","article-title":"Novel allosteric modulator Southern research Institute-32743 reverses HIV-1 transactivator of transcription-induced increase in dopamine release in the caudate putamen of inducible transactivator of transcription transgenic mice","volume":"384","author":"Davis","year":"2023","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178131_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00002826-200007000-00004","article-title":"Decreased homovanilic acid in cerebrospinal fluid correlates with impaired neuropsychologic function in HIV-1-infected patients","volume":"23","author":"di Rocco","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib12","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2025.178131_bib13","article-title":"Comparative protein structure modeling using modeller","volume":"5","author":"Eswar","year":"2006","journal-title":"Curr. Protoc. Bioinformatics Chapter"},{"key":"10.1016\/j.ejphar.2025.178131_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.287.5453.602","article-title":"HIV infection and dementia","volume":"287","author":"Gartner","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178131_bib15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2353\/ajpath.2009.081067","article-title":"Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse","volume":"175","author":"Gaskill","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.178131_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nbd.2017.04.015","article-title":"HIV, Tat and dopamine transmission","volume":"105","author":"Gaskill","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2025.178131_bib17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s11481-012-9345-4","article-title":"Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis","volume":"7","author":"Gelman","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib18","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2025.178131_bib19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-013-1086-x","article-title":"Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10\/10-repeat allele which is more frequent in HIV-infected individuals","volume":"120","author":"Horn","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2025.178131_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.1973.tb07533.x","article-title":"Structure activity relations for the inhibition of 5-HT uptake into rat hypothalamic homogenates by serotonin and tryptamine analogues","volume":"21","author":"Horn","year":"1973","journal-title":"J. Neurochem."},{"issue":"14","key":"10.1016\/j.ejphar.2025.178131_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147881","article-title":"Effects of SRI-32743, a novel quinazoline structure-based compound, on HIV-1 Tat and cocaine interaction with norepinephrine transporter","volume":"25","author":"Jimenez-Torres","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178131_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M","article-title":"[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux","volume":"30","author":"Johnson","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2025.178131_bib22","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1073\/pnas.1308673110","article-title":"Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein","volume":"110","author":"Johnson","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178131_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/QAD.0000000000003379","article-title":"The global burden of cognitive impairment in people with HIV","volume":"37","author":"Keng","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.ejphar.2025.178131_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.micinf.2005.11.014","article-title":"HIV tat and neurotoxicity","volume":"8","author":"King","year":"2006","journal-title":"Microb. Infect."},{"key":"10.1016\/j.ejphar.2025.178131_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s007020200063","article-title":"Parkinsonism in HIV dementia","volume":"109","author":"Koutsilieri","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2025.178131_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13550280902973952","article-title":"Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains","volume":"15","author":"Kumar","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.ejphar.2025.178131_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13365-010-0003-4","article-title":"Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance","volume":"17","author":"Kumar","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.ejphar.2025.178131_bib28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"Mega X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ejphar.2025.178131_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jnr.490280313","article-title":"Cerebrospinal fluid catecholamine metabolites in HIV-infected patients","volume":"28","author":"Larsson","year":"1991","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2025.178131_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-61779-465-0_10","article-title":"Rosetta Ligand docking with flexible XML protocols","volume":"819","author":"Lemmon","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2025.178131_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fimmu.2016.00397","article-title":"Targeting the brain reservoirs: toward an HIV cure","volume":"7","author":"Marban","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178131_bib32","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/bioinformatics\/bty355","article-title":"Efficient flexible backbone protein-protein docking for challenging targets","volume":"34","author":"Marze","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejphar.2025.178131_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human immunodeficiency virus-associated neurocognitive disorders: mind the gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2025.178131_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11481-013-9464-6","article-title":"Mutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions","volume":"8","author":"Midde","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11481-015-9583-3","article-title":"Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport","volume":"10","author":"Midde","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.neuro.24.1.167","article-title":"An integrative theory of prefrontal cortex function","volume":"24","author":"Miller","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178131_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12883-020-01857-3","article-title":"HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya","volume":"20","author":"Mohamed","year":"2020","journal-title":"BMC Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2025.178131_bib38","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1086\/344528","article-title":"Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia","volume":"186","author":"Nath","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"15","key":"10.1016\/j.ejphar.2025.178131_bib68","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1093\/emboj\/17.15.4266","article-title":"Delineation of an endogenous zinc-binding site in the human dopamine transporter","volume":"17","author":"Norregaard","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.ejphar.2025.178131_bib39","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00415-009-5052-3","article-title":"Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV","volume":"256","author":"Obermann","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2025.178131_bib40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The paradox of HIV blood-brain barrier penetrance and antiretroviral drug delivery deficiencies","volume":"43","author":"Osborne","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2025.178131_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13365-012-0147-5","article-title":"The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons","volume":"19","author":"Overton","year":"2013","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.ejphar.2025.178131_bib42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0764-4469(00)01228-2","article-title":"1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein","volume":"323","author":"Peloponese","year":"2000","journal-title":"C R Acad. Sci. III"},{"key":"10.1016\/j.ejphar.2025.178131_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature12533","article-title":"X-ray structure of dopamine transporter elucidates antidepressant mechanism","volume":"503","author":"Penmatsa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178131_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep39048","article-title":"Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport","volume":"6","author":"Quizon","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejphar.2025.178131_bib45","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s11481-021-09984-5","article-title":"Mutations of Human DopamineTransporter at Tyrosine88, aspartic Acid206, and Histidine547 influence basal and HIV-1 tat-inhibited dopamine transport","volume":"16","author":"Quizon","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib46","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/13548506.2011.579992","article-title":"HIV-related neurocognitive impairment--a review","volume":"16","author":"Rackstraw","year":"2011","journal-title":"Psychol. Health Med."},{"key":"10.1016\/j.ejphar.2025.178131_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(77)90202-3","article-title":"Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine","volume":"41","author":"Raiteri","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178131_bib48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jlb.65.4.458","article-title":"Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat","volume":"65","author":"Rappaport","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2025.178131_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneumeth.2004.09.015","article-title":"Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity","volume":"143","author":"Reith","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2025.178131_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bandc.2004.09.016","article-title":"Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning","volume":"56","author":"Ridderinkhof","year":"2004","journal-title":"Brain Cognit."},{"key":"10.1016\/j.ejphar.2025.178131_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/jpet.111.188946","article-title":"Studies of the biogenic amine transporters. 14. Identification of low-efficacy \"partial\" substrates for the biogenic amine transporters","volume":"341","author":"Rothman","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178131_bib52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00001756-199603220-00015","article-title":"Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS","volume":"7","author":"Sardar","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2025.178131_bib53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","article-title":"HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2025.178131_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00702-010-0415-6","article-title":"Increased dopaminergic neurotransmission in therapy-naive asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses","volume":"117","author":"Scheller","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2025.178131_bib55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0022-3565(24)39309-7","article-title":"Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter","volume":"293","author":"Scholze","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178131_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.120.266023","article-title":"[(3)H]Dopamine uptake through the dopamine and norepinephrine transporters is decreased in the prefrontal cortex of transgenic mice expressing HIV-1 transactivator of transcription protein","volume":"374","author":"Strauss","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178131_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0275182","article-title":"Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function","volume":"17","author":"Strauss","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.178131_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrn1008","article-title":"Plasma membrane monoamine transporters: structure, regulation and function","volume":"4","author":"Torres","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178131_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/375497a0","article-title":"Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120","volume":"375","author":"Westendorp","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178131_bib60","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1073\/pnas.97.21.11466","article-title":"Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1","volume":"97","author":"Xiao","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178131_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/acschemneuro.5b00001","article-title":"Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter","volume":"6","author":"Yuan","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178131_bib62","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.4155\/fmc-2016-0138","article-title":"Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription","volume":"8","author":"Yuan","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178131_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneumeth.2011.08.044","article-title":"Characterization of [(3)H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive","volume":"203","author":"Zhen","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2025.178131_bib64","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/syn.20949","article-title":"Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity","volume":"65","author":"Zhu","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2025.178131_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109239","article-title":"SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice","volume":"220","author":"Zhu","year":"2022","journal-title":"Neuropharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:38:46Z","timestamp":1780202326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925008854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":69,"alternative-id":["S0014299925008854"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178131","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutational effects of the asparagine198 and glutamate223 residues on the human norepinephrine transporter on basal and HIV-1 Tat protein-induced inhibition of dopamine transport","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178131"}}